Your browser doesn't support javascript.
loading
Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.
Zhu, Zheng; Wang, Jiao; Tan, Juan; Yao, Yue-Liang; He, Zhi-Cheng; Xie, Xiao-Qing; Yan, Ze-Xuan; Fu, Wen-Juan; Liu, Qing; Wang, Yan-Xia; Luo, Tao; Bian, Xiu-Wu.
Afiliação
  • Zhu Z; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Wang J; Research Department, PLA Rocket Force Characteristic Medical Center, Beijing, PR China.
  • Tan J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Yao YL; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • He ZC; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Xie XQ; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Yan ZX; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Fu WJ; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Liu Q; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Wang YX; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Luo T; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
  • Bian XW; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University) and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, PR China.
J Pathol ; 255(4): 374-386, 2021 12.
Article em En | MEDLINE | ID: mdl-34370292

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas de Ligação ao Cálcio / Glioma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteínas de Ligação ao Cálcio / Glioma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Ano de publicação: 2021 Tipo de documento: Article